10 Best Biotech Stocks To Buy Right Now: Lpath Inc (LPTN)Lpath, Inc. (Lpath), incorporated on September 18, 2002, is a biotechnology company focused on the discovery and development of bio-active lipid-targeted monoclonal antibody (mAb) therapeutics. The Company has three product candidates, iSONEP, ASONEP and Lpathomab. The Company’s program, iSONEP, is a mAb against Sphingosine-1-Phosphate (S1P). As of December 31, 2012, […]
We run down all the current open positions in the portfolio, with a brief snapshot of how each one is performing, along with our future guidance for the stocks.LoginEnter your username and password belowForgot Your Password?
Greg Miller has spent over 20 years in the financial industry, working up from analyst, to portfolio manager, and eventually to an institutional investor, where […]
This has been a weird June. The SPX is up like 5 handles. The Dow is flat to up maybe one percent. If it wasn’t for biotech, where would the Nasdaq be? Really.The best way to deal with any issues in trading is simple…listen to what the market is telling you. The choppier the day to day action has been, […]
Download Letter (PDF)June 12, 2015Crescat Capital Quarterly Investor Letter Q2 2015Performance UpdateWe are pleased to report that the Crescat Global Macro Fund was recently named one of the top-ten performing global macro hedge funds by BarclayHedge for the three years ended 3/31/2015. As shown in the table below, all three Crescat strategies performed strongly in Q1 while the S&P 500 […]
Today is a relatively interesting day for the biotech world; and looking at the stocks in the space, there are several possibly profitable opportunities starting to emerge. With that said, today we’re going to look at the 4 different biotech stocks that I think are presenting the largest opportunities at the moment. Here’s what I see…Aoxing Pharmaceutical Company Stock Is […]
Submitted by Tyler Durden: It is no secret that US healthcare corporations have been among, if not the biggest beneficiaries of Obamacare: by “socializing” costs and spreading the reimbursement pool over the entire population in the form of a tax, pharmaceutical companies have been able to boost medical product and service costs to unprecedented levels with the help of complicit […]
It is no secret that US healthcare corporations have been among, if not the biggest beneficiaries of Obamacare: by “socializing” costs and spreading the reimbursement pool over the entire population in the form of a tax, pharmaceutical companies have been able to boost medical product and service costs to unprecedented levels with the help of complicit insurance companies who have […]
It is no secret that in recent weeks Goldman has been particular bearish (if only to the outside world), with statements such as the following by chief equity strategist David Kostin:
… by almost any measure, US equity valuations look expensive. The typical stock in the S&P 500 trades at 18.1x forward earnings, ranking at the 98th percentile of historical valuation […]
More here –
General progress
See which stocks are being affected by Social Media
[…]
Biotech stocks have been in a strong Upward trend for years. Both ETFs Nasdaq (IBB) and S&P (XBI) have been top performers. Recently the S&P (XBI) has rallied on to all time highs. The Nasdaq (IBB) has failed to take out all time highs. The Proshares Nasdaq Biotech ETF (2X) (BIB) is an excellent instrument. Now Direxionshares has recently introduced […]
